Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Aldosteronoma.

Laurent Brunaud1, Quan-Yang Duh

  • 1Department of Surgery, University of California, San Francisco/Mount Zion Medical Center, 94143-1674, USA.

Current Treatment Options in Oncology
|June 21, 2002
PubMed
Summary
This summary is machine-generated.

Aldosteronoma, a surgically curable hypertension cause, is more common than previously thought. Screening all hypertensive patients, even those with normal potassium, is crucial for effective treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Surgery is no longer the only effective treatment for obesity: What does this means?

Journal of visceral surgery·2026
Same author

Predicting Best Performers After Minimally Invasive Left Pancreatectomy: Insights From a National Cohort.

Annals of surgery·2026
Same author

What Price Would You Pay to Avoid a Thyroidectomy Scar?

World journal of surgery·2026
Same author

Acylcarnitines Are Associated with Metabolic Syndrome and Hypertension in Two Contrasted Obese Populations.

Nutrients·2026
Same author

More liberal use of bilateral adrenalectomy for bilateral adrenal tumours with cortisol excess.

The lancet. Diabetes & endocrinology·2026
Same author

Parathyroid autofluorescence: A conditionally cost-effective tool to reduce postoperative hypocalcemia after total thyroidectomy.

Surgery·2025
Same journal

Interaction between Regulated Cell Death Pathways and Core Cellular Processes: Unraveling the Molecular Mechanisms of Cardiotoxicity of Antitumor Drugs.

Current treatment options in oncology·2026
Same journal

Advances in Immunotherapy for Breast Cancer: Up-to-date Strategies of Immune Checkpoint Inhibitors and Therapeutic Vaccines.

Current treatment options in oncology·2026
Same journal

Recent Advances in Neoadjuvant Treatment of Anaplastic Thyroid Carcinoma: A Narrative Review.

Current treatment options in oncology·2026
Same journal

The Immunological Landscape of the Tumor Microenvironment: Implications for Immunotherapy of Unresectable and Metastatic Soft Tissue Sarcomas.

Current treatment options in oncology·2026
Same journal

Oncofertility in the Age of HER2 Blockade, Immunotherapy, PARP inhibitors, CDK4/6 inhibitors and Endocrine Treatment: Unanswered Questions in Breast Cancer.

Current treatment options in oncology·2026
Same journal

Emerging Applications of CAR-T Cell Therapy in Overcoming Resistance and Expanding Targets in Hematologic Malignancies: Insights from Recent Research.

Current treatment options in oncology·2026
See all related articles

Area of Science:

  • Endocrinology
  • Surgical Oncology
  • Nephrology

Background:

  • Aldosteronoma is an increasingly recognized cause of secondary hypertension.
  • Previously underestimated, it affects at least 2% of hypertensive patients.
  • Many patients with aldosteronoma are normokalemic, complicating diagnosis.

Purpose of the Study:

  • To highlight the prevalence and diagnostic considerations of aldosteronoma.
  • To emphasize the importance of screening for primary hyperaldosteronism in hypertensive individuals.
  • To discuss current diagnostic and surgical management strategies.

Main Methods:

  • Review of recent studies on aldosteronoma prevalence and clinical presentation.
  • Discussion of diagnostic criteria including laboratory tests and imaging.

Related Experiment Videos

  • Description of surgical approaches, including laparoscopic resection.

    • Main Results:

    • Aldosteronomas are a common, surgically curable cause of hypertension.
    • Over 50% of patients with aldosteronoma present with normal serum potassium levels.
    • High-resolution CT scanning aids in differentiating adrenal adenoma from hyperplasia.

    Conclusions:

    • Hypertensive patients require screening for primary hyperaldosteronism irrespective of potassium levels.
    • Early diagnosis and surgical intervention (adrenalectomy) improve outcomes.
    • Laparoscopic adrenalectomy is the standard surgical treatment for aldosteronoma.